Versamet Royalties Corporation
Financial Statements (IFRS) · Amounts in CAD
Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 |
|---|---|---|---|
| Total Revenue | 12.0M | 3.1M | -- |
| Operating Revenue | 12.0M | 3.1M | -- |
| Cost Of Revenue | 10.8M | 2.3M | -- |
| Gross Profit | 1.2M | 842,465 | -- |
| Selling General And Administration | 5.5M | 3.4M | -- |
| General And Administrative Expense | 5.5M | 3.4M | -- |
| Other Operating Expenses | 49,438 | 33,945 | -- |
| Operating Expense | 5.5M | 3.4M | -- |
| Operating Income | -4.3M | -2.6M | -- |
| EBIT | 2.7M | -494,339 | -- |
| Interest Expense | 3.6M | 2.0M | -- |
| Interest Expense Non Operating | 3.6M | 2.0M | -- |
| Interest Income | 148,219 | 112,479 | -- |
| Interest Income Non Operating | 148,219 | 112,479 | -- |
| Net Interest Income | -3.4M | -1.9M | -- |
| Other Income Expense | 6.9M | 2.0M | -- |
| Special Income Charges | -8.3M | -2.4M | -- |
| Write Off | 0.00 | 401,557 | -- |
| Gain On Sale Of Security | 15.2M | 4.4M | -- |
| Pretax Income | -873,433 | -2.5M | -- |
| Tax Provision | 1.6M | 619,224 | -- |
| Tax Effect Of Unusual Items | 1.0M | 798,813 | -- |
| Net Income From Continuing And Discontinued Operation | -2.4M | -3.1M | -- |
| Net Income From Continuing Operation Net Minority Interest | -2.4M | -3.1M | -- |
| Net Income Including Noncontrolling Interests | -2.4M | -3.1M | -- |
| Net Income Common Stockholders | -2.4M | -3.1M | -- |
| Net Income | -2.4M | -3.1M | -- |
| EBITDA | 3.5M | 406,198 | -- |
| Normalized EBITDA | -3.3M | -1.6M | -- |
| Reconciled Depreciation | 842,729 | 900,537 | -- |
| Basic EPS | -0.03 | -0.03 | -- |
| Diluted EPS | -0.03 | -0.03 | -- |
| Basic Average Shares | 92.8M | 92.8M | -- |
| Diluted Average Shares | 92.8M | 92.8M | -- |
| Total Unusual Items | 6.9M | 2.0M | -- |
| Total Unusual Items Excluding Goodwill | 6.9M | 2.0M | -- |
| Tax Rate For Calcs | 0.15 | 0.40 | -- |
| Normalized Income | -8.3M | -4.3M | -- |
| Diluted NI Availto Com Stockholders | -2.4M | -3.1M | -- |
| Impairment Of Capital Assets | 8.3M | 2.0M | -- |
| Net Income Continuous Operations | -2.4M | -3.1M | -- |
| Net Non Operating Interest Income Expense | -3.4M | -1.9M | -- |
| Other Gand A | 894,980 | 886,717 | -- |
| Reconciled Cost Of Revenue | 10.8M | 2.3M | -- |
| Salaries And Wages | 4.6M | 2.5M | -- |
| Total Expenses | 16.4M | 5.7M | -- |
| Total Operating Income As Reported | 1.4M | -216,652 | -- |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 1.4M | 6.7M | 4.1M |
| Cash Cash Equivalents And Short Term Investments | 1.4M | 6.7M | 4.1M |
| Accounts Receivable | 369,066 | 421,462 | 771,685 |
| Receivables | 369,066 | 421,462 | 3.0M |
| Other Current Assets | 7.7M | 5.7M | 7,270 |
| Current Assets | 9.5M | 12.8M | 7.1M |
| Gross PPE | 232.9M | 146.9M | 70.6M |
| Accumulated Depreciation | -12.8M | -3.7M | -- |
| Net PPE | 220.1M | 143.2M | 70.6M |
| Investments And Advances | 729,981 | 1.7M | 1.6M |
| Total Non Current Assets | 220.8M | 144.9M | 72.1M |
| Total Assets | 230.2M | 157.7M | 79.2M |
| Current Debt | 12.3M | 12.6M | 8.8M |
| Current Debt And Capital Lease Obligation | 12.3M | 12.6M | 8.8M |
| Accounts Payable | 1.2M | 226,024 | 111,935 |
| Payables | 1.2M | 226,024 | 111,935 |
| Payables And Accrued Expenses | 1.2M | 226,024 | 111,935 |
| Other Current Liabilities | 3.3M | 3.7M | -- |
| Current Liabilities | 16.9M | 16.5M | 8.9M |
| Long Term Debt | 608,442 | 27.1M | 6.3M |
| Long Term Debt And Capital Lease Obligation | 608,442 | 27.1M | 6.3M |
| Total Non Current Liabilities Net Minority Interest | 2.1M | 27.5M | 6.5M |
| Total Liabilities Net Minority Interest | 18.9M | 44.0M | 15.5M |
| Common Stock | 215.8M | 118.3M | 66.8M |
| Capital Stock | 215.8M | 118.3M | 66.8M |
| Retained Earnings | -8.0M | -5.5M | -2.4M |
| Gains Losses Not Affecting Retained Earnings | -1.2M | -1.4M | -1.5M |
| Other Equity Adjustments | -1.2M | -1.4M | -1.5M |
| Common Stock Equity | 211.3M | 113.8M | 63.7M |
| Stockholders Equity | 211.3M | 113.8M | 63.7M |
| Total Equity Gross Minority Interest | 211.3M | 113.8M | 63.7M |
| Total Capitalization | 211.9M | 140.9M | 70.1M |
| Net Tangible Assets | 211.3M | 113.8M | 63.7M |
| Tangible Book Value | 211.3M | 113.8M | 63.7M |
| Working Capital | -7.4M | -3.7M | -1.9M |
| Invested Capital | 224.3M | 153.4M | 78.9M |
| Total Debt | 12.9M | 39.7M | 15.1M |
| Net Debt | 11.5M | 32.9M | 11.1M |
| Share Issued | 92.8M | 92.8M | 92.8M |
| Ordinary Shares Number | 92.8M | 92.8M | 92.8M |
| Non Current Deferred Liabilities | 1.5M | 397,380 | 212,944 |
| Non Current Deferred Taxes Liabilities | 1.5M | 397,380 | 212,944 |
| Notes Receivable | 0.00 | 0.00 | 2.2M |
| Other Current Borrowings | 12.3M | 12.6M | 8.8M |
| Other Equity Interest | 4.8M | 2.4M | 801,191 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 |
|---|---|---|---|
| Operating Cash Flow | 7.4M | 621,273 | -- |
| Cash Flow From Continuing Operating Activities | 7.4M | 621,273 | -- |
| Depreciation Amortization Depletion | 842,729 | 900,537 | -- |
| Stock Based Compensation | 2.6M | 1.6M | -- |
| Deferred Tax | 1.6M | 619,224 | -- |
| Deferred Income Tax | 1.6M | 619,224 | -- |
| Change In Working Capital | 856,851 | 21,876 | -- |
| Change In Receivables | 75,863 | -95,159 | -- |
| Change In Payables And Accrued Expense | 780,988 | 117,035 | -- |
| Other Non Cash Items | 3.4M | 1.9M | -- |
| Purchase Of Business | -75,975 | -62.5M | -- |
| Sale Of Investment | 1.0M | 0.00 | -- |
| Net Investment Purchase And Sale | 1.0M | 0.00 | -- |
| Investing Cash Flow | 956,095 | -60.3M | -- |
| Cash Flow From Continuing Investing Activities | 956,095 | -60.3M | -- |
| Issuance Of Debt | 0.00 | 41.1M | -- |
| Repayment Of Debt | -19.0M | -6.3M | -- |
| Net Issuance Payments Of Debt | -19.0M | 34.7M | -- |
| Issuance Of Capital Stock | 7.5M | 27.5M | -- |
| Net Common Stock Issuance | 7.5M | 27.5M | -- |
| Financing Cash Flow | -13.5M | 62.2M | -- |
| Cash Flow From Continuing Financing Activities | -13.5M | 62.2M | -- |
| Effect Of Exchange Rate Changes | -149,886 | 130,930 | -- |
| Changes In Cash | -5.1M | 2.5M | -- |
| Beginning Cash Position | 6.7M | 4.1M | -- |
| End Cash Position | 1.4M | 6.7M | -- |
| Free Cash Flow | 7.4M | 621,273 | -- |
| Asset Impairment Charge | 8.3M | 2.4M | -- |
| Cash Dividends Paid | 0.00 | 0.00 | -- |
| Common Stock Issuance | 7.5M | 27.5M | -- |
| Depletion | 842,729 | 900,537 | -- |
| Gain Loss On Investment Securities | -399,893 | 3,691 | -- |
| Gain Loss On Sale Of PPE | 8.0M | 1.1M | -- |
| Interest Paid Cff | -2.0M | -15,113 | -- |
| Long Term Debt Issuance | 0.00 | 41.1M | -- |
| Long Term Debt Payments | -19.0M | -6.3M | -- |
| Net Business Purchase And Sale | -75,975 | -62.5M | -- |
| Net Foreign Currency Exchange Gain Loss | -796,539 | 382,243 | -- |
| Net Income From Continuing Operations | -2.4M | -3.1M | -- |
| Net Long Term Debt Issuance | -19.0M | 34.7M | -- |
| Net Other Investing Changes | -- | 2.2M | -- |
| Operating Gains Losses | 6.8M | 1.5M | -- |
| Taxes Refund Paid | -509,132 | -434,788 | -- |
| Unrealized Gain Loss On Investment Securities | -14.1M | -4.8M | -- |